Machine Learning for Stroke Risk Prediction: Application of Medical AI in Early Disease Warning

This project was published by pabliik on GitHub (Project link: https://github.com/pabliik/stroke-prediction, published on June 4, 2026). It aims to predict stroke risk by analyzing patient data using machine learning techniques with classification algorithms, addressing the limitations of traditional assessment tools, providing support for early disease warning and personalized prevention, and demonstrating the application value of medical AI in the health field.

Stroke is the second leading cause of death globally, with over 15 million people affected each year, 5 million deaths, and 5 million permanent disabilities. Its risk factors accumulate over the long term, but traditional assessment tools (such as CHADS2-VASc) have limitations like linear assumptions, fixed weights, and rigid thresholds. This project uses ML to identify risk patterns and assist in early intervention.

Feature Engineering covers demographics (age, gender, etc.), physiological indicators (blood pressure, blood glucose, etc.), medical history records (cardiovascular diseases, etc.), lifestyle (smoking, drinking, etc.), and other factors (genetics, environment). Algorithm Selection includes binary classification algorithms such as logistic regression (baseline, strong interpretability), random forest (ensemble learning, good robustness), gradient boosting trees (handling imbalanced data), SVM (small samples), and neural networks (large-scale data).

Need to address class imbalance (low stroke incidence, using metrics like F1, AUC-ROC), cost-sensitive learning (missed diagnosis cost is higher than misdiagnosis, prioritize recall rate), and clinical interpretability (use SHAP/LIME to explain predictions and visualize feature contributions).

Data Quality: missing values, noise, bias, privacy protection; Model Deployment: real-time performance, integration with EMR, update monitoring; Regulatory Compliance: FDA/NMPA approval, clinical trial validation, continuous monitoring.

Multimodal Fusion (imaging, genomics, wearables, NLP); Temporal Modeling (RNN/LSTM for dynamic risk change monitoring); Personalized Intervention (recommend prevention plans, predict intervention effects).

The project demonstrates the potential of ML in healthcare, helping to early identify high-risk groups. Success requires high-quality data, domain knowledge, ethical considerations, and continuous validation. In the future, ML will play a greater role in disease prevention, diagnosis, and personalized treatment, promoting the ideal of 'preventing disease before it occurs'.